Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress) Meeting Abstract
| Authors: | Powles, T.; Grande, E.; Van Der Heijden, M.; Necchi, A.; Iyer, G.; Drakaki, A.; Loriot, Y.; Sokolowski, K.; Zhang, W.; Galsky, M. |
| Abstract Title: | Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress) |
| Meeting Title: | 39th Annual EAU Congress (EAU24) |
| Journal Title: | European Urology |
| Volume: | 85 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Apr 5-8 |
| Meeting Location: | Paris, France |
| ISSN: | 0302-2838 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-03-01 |
| Start Page: | S1721 |
| Language: | English |
| ACCESSION: | WOS:001282821401483 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0302-2838(24)01317-4 |
| Notes: | Meeting Abstract: A0746 -- Source: Wos |
